VP, Research and Head of Small Molecule Therapeutic Discovery (SMTD)
Amgen
Head, Lipid Nanoparticle Platform
Takeda Pharmaceuticals
Co-founder
INTREPID
Scientific Consultant
The INTREPID Alliance, Inc was registered as a Delaware non-stock corporation in April 2021, to provide a framework for start-up activities.
The Board, consisting of 7 founding member companies was elected on May 19, 2022, and terms of reference were agreed.
For more information and membership inquiries contact [email protected].